Show simple item record

dc.contributor.authorMarsden, J R
dc.contributor.authorNewton-Bishop, J
dc.contributor.authorBurrows, L
dc.contributor.authorCook, M
dc.contributor.authorCorrie, P G
dc.contributor.authorCox, N H
dc.contributor.authorGore, M E
dc.contributor.authorLorigan, Paul C
dc.contributor.authorMackie, R
dc.contributor.authorNathan, P
dc.contributor.authorPeach, H
dc.contributor.authorPowell, B
dc.contributor.authorWalker, C
dc.date.accessioned2010-11-18T15:50:11Z
dc.date.available2010-11-18T15:50:11Z
dc.date.issued2010-09
dc.identifier.citationRevised UK guidelines for the management of cutaneous melanoma 2010. 2010, 63 (9):1401-19 J Plast Reconstr Aesthet Surgen
dc.identifier.issn1878-0539
dc.identifier.pmid20728418
dc.identifier.doi10.1016/j.bjps.2010.07.006
dc.identifier.urihttp://hdl.handle.net/10541/115847
dc.description.abstractThese guidelines for the management of cutaneous melanoma present an evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiology, diagnosis, investigation, and follow-up.
dc.language.isoenen
dc.subjectSkin Canceren
dc.subject.meshBiopsy
dc.subject.meshDiagnostic Imaging
dc.subject.meshEvidence-Based Medicine
dc.subject.meshGreat Britain
dc.subject.meshHumans
dc.subject.meshLymphatic Metastasis
dc.subject.meshMelanoma
dc.subject.meshPopulation Surveillance
dc.subject.meshPractice Guidelines as Topic
dc.subject.meshPrognosis
dc.subject.meshReferral and Consultation
dc.subject.meshRisk Factors
dc.subject.meshSkin Neoplasms
dc.subject.meshSocieties, Medical
dc.titleRevised UK guidelines for the management of cutaneous melanoma 2010.en
dc.typeArticleen
dc.contributor.departmentUniversity Hospital Birmingham, Birmingham B29 6JD, United Kingdom. jerry.marsden@uhb.nhs.uken
dc.identifier.journalJournal of Plastic, Reconstructive & Aesthetic Surgeryen
html.description.abstractThese guidelines for the management of cutaneous melanoma present an evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiology, diagnosis, investigation, and follow-up.


Files in this item

This item appears in the following Collection(s)

Show simple item record